TSE:ASP Acerus Pharmaceuticals (ASP) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free ASP Stock Alerts Add Compare Share Share Today's Range N/A50-Day RangeC$0.36▼C$0.3652-Week Range N/AVolume1,250 shsAverage Volume4,719 shsMarket CapitalizationC$2.78 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Acerus Pharmaceuticals alerts: Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About Acerus Pharmaceuticals Stock (TSE:ASP)Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; and Noctiva, a vasopressin analog indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void. It also engages in developing Lidbree, a short acting lidocaine formulation delivered through a proprietary device into the vaginal mucosal tissue; Stendra, a PDE5 inhibitor for the treatment of erectile dysfunction; Tefina, a clinical stage product for women with female sexual dysfunction; and Noctiva combination products, which are in the pre-clinical development stage for the treatment of benign prostatic hypertrophy, overactive bladder, and pediatric nocturnal enuresis. In addition, the company provides TriVair technology platform for pulmonary and nasal dosing. It sells its products through its salesforce in the United States and Canada; and through a network of distributors internationally. The company was formerly known as Trimel Pharmaceuticals Corporation and changed its name to Acerus Pharmaceuticals Corporation in September 2015. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada.Read More Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… ASP Stock News HeadlinesMay 25, 2023 | benzinga.comAcerus UpdateApril 8, 2023 | theglobeandmail.comClosing Bell: Acerus Pharmaceuticals Corp flat on Thursday (ASP)March 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.January 26, 2023 | finance.yahoo.comIIROC Trading Halt - ASPJanuary 26, 2023 | finance.yahoo.comAcerus Files For CCAA ProtectionDecember 22, 2022 | finance.yahoo.comAcerus Announces New Loan Agreement With First Generation CapitalNovember 18, 2022 | finance.yahoo.comAcerus Pharmaceuticals Third Quarter 2022 Earnings: US$0.54 loss per share (vs US$0.64 loss in 3Q 2021)November 14, 2022 | sfgate.comAcerus: Q3 Earnings SnapshotMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.August 3, 2022 | finance.yahoo.comAcerus to Report Q2-2022 Financial Results and Host Investor CallJune 7, 2022 | finance.yahoo.comAcerus Announces Amendment and Restatement of the Promissory Note Related to the Up-Front Fee Payable to Former Serenity SecurityholdersMay 10, 2022 | finance.yahoo.comAcerus Reports First Quarter 2022 Financial ResultsApril 27, 2022 | finanznachrichten.deAcerus Pharmaceuticals Corporation: Acerus Announces Completion of Share ConsolidationMarch 10, 2022 | ca.finance.yahoo.comStocks in play: Acerus Pharmaceuticals Corporation.March 10, 2022 | finance.yahoo.comAcerus To Report Q4 And Full Year 2021 Financial Results And Host Investor CallMarch 7, 2022 | stockhouse.comAcerus Announces Closing of Acquisition of Serenity Pharmaceuticals LLC and Acquisition of Global Rights to Noctiva(TM)February 18, 2022 | finance.yahoo.comAcerus Announces Amendment to Loan FacilitiesJanuary 10, 2022 | finance.yahoo.comAcerus Pharmaceuticals Announces Commercial Agreement With Verity Pharmaceuticals for the Promotion of NATESTO® in Puerto RicoDecember 13, 2021 | finance.yahoo.comAcerus Announces Amendments to Loan FacilitiesNovember 2, 2021 | finance.yahoo.comAcerus to Report Q3-2021 Financial Results and Host Investor CallOctober 26, 2021 | finance.yahoo.comResearch Reports Initiated on Healthcare Stocks Nuvo Pharmaceuticals, Acerus Pharmaceuticals, and AvivagenSeptember 9, 2021 | finance.yahoo.comEven with Acerus Pharmaceuticals Corporation (TSE:ASP) stock down 11% this week, insiders who bought recently netted around US$102kAugust 21, 2021 | barrons.comAcerus Pharmaceuticals Corp.August 12, 2021 | finance.yahoo.comAcerus Reports Acceptance of Part 36 Settlement Offer in Recipharm LitigationAugust 3, 2021 | finance.yahoo.comAcerus to Report Q2-2021 Financial Results and Host Investor CallSee More Headlines Receive ASP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acerus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolTSE:ASP CUSIPN/A CIKN/A Webwww.aceruspharma.com Phone416-679-0771FaxN/AEmployees14Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($4.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-28,080,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-54.10% Debt Debt-to-Equity Ratio261.01 Current Ratio0.67 Quick Ratio0.26 Sales & Book Value Annual SalesC$3.04 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow3.29 Book ValueC($1.80) per share Price / BookN/AMiscellaneous Outstanding Shares7,710,000Free FloatN/AMarket CapC$2.78 million OptionableNot Optionable Beta1.03 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Edward GudaitisPres, CEO & DirectorMr. Gavin DamstraSr. VP of International CommercialDr. Christopher Sorli F.A.C.E.M.D., Ph.D., Chief Medical OfficerMr. Kevin Thomas HickeySr. VP of US CommercialMr. Naveed ManzoorInterim Chief Financial OfficerMr. Chris WittyInvestor RelationsMr. Philippe SavardSr. VP, Gen. Counsel & Corp. Sec.Mr. Hubert Tomasz CzerwinskiPres of Acerus Pharmaceuticals SRLMore ExecutivesKey CompetitorsRadient TechnologiesCVE:RTIEntourage HealthCVE:ENTGAequus PharmaceuticalsCVE:AQSEve & Co IncorporatedCVE:EVENeutriSci InternationalCVE:NUView All Competitors ASP Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Acerus Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Acerus Pharmaceuticals investors own include Aurora Cannabis (ACB), Surna (SRNA), Allena Pharmaceuticals (ALNA), Molecular Templates (MTEM), Avid Bioservices (CDMO), OHR Pharmaceutical (OHRP), Trilogy International Partners (TRL), Absolute Software Co. (ABT.TO) (ABT), Ampliphi Biosciences (APHB) and Algonquin Power & Utilities (AQN). How do I buy shares of Acerus Pharmaceuticals? Shares of ASP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:ASP) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acerus Pharmaceuticals Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.